Pharmaceutical

Boehringer Ingelheim and Salipro enter drug discovery partnership

Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.

Mar 15, 2025 - 06:00
Boehringer Ingelheim and Salipro enter drug discovery partnership
Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement for drug targets' development.
Read the original article

Tags:

Previous Article

AstraZeneca director says AI must be a “thought partner” in drug discovery

Next Article

MeiraGTx and Hologen launch AI-backed gene therapy venture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Moderna and Generation Bio partner for genetic medicines development

Moderna and Generation Bio partner for genetic medicine...

Mar 25, 2023

Opinion: Congress can eradicate hepatitis C and reduce the deficit at the same time

Opinion: Congress can eradicate hepatitis C and reduce ...

Jul 14, 2023

BMS wins approval for schizophrenia drug acquired from Karuna

BMS wins approval for schizophrenia drug acquired from ...

Sep 28, 2024